Masson C, Scandola C, Rinckel JY, Proamer F, Janus-Bell E, Batool F, Osmani N, Goetz JG, Mallo L, Brouard N, Leon C, Bornert A, Poincloux R, Destaing O, Mansson A, Qian H, Lehmann M, Eckly A

Elife. 2025 10 8;14:

Biotinylated Fluorescent Polymeric Nanoparticles for Enhanced Immunostaining.

Yudhistira T, Da Silva EC, Combes A, Lehmann M, Reisch A, Klymchenko AS

Small Methods. 2023 02 19;:e2201452

Bioimaging Nucleic-Acid Aptamers with Different Specificities in Human Glioblastoma Tissues Highlights Tumoral Heterogeneity.

Cruz Da Silva E, Foppolo S, Lhermitte B, Ingremeau M, Justiniano H, Klein L, Chenard MP, Vauchelles R, Abdallah B, Lehmann M, Etienne-Selloum N, Dontenwill M, Choulier L

Pharmaceutics. 2022 09 20;14(10):

Advanced quantification for single-cell adhesion by variable-angle TIRF nanoscopy.

El Arawi D, Vézy C, Déturche R, Lehmann M, Kessler H, Dontenwill M, Jaffiol R

Biophys Rep (N Y). 2021 12 8;1(2):100021

Role of Endocytosis Proteins in Gefitinib-Mediated EGFR Internalisation in Glioma Cells.

Cruz Da Silva E, Choulier L, Thevenard-Devy J, Schneider C, Carl P, Rondé P, Dedieu S, Lehmann M

Cells. 2021 Nov 21;10(11):

Inhibiting FAK-Paxillin Interaction Reduces Migration and Invadopodia-Mediated Matrix Degradation in Metastatic Melanoma Cells.

Mousson A, Legrand M, Steffan T, Vauchelles R, Carl P, Gies JP, Lehmann M, Zuber G, De Mey J, Dujardin D, Sick E, Rondé P

Cancers (Basel). 2021 Apr 14;13(8):

Gefitinib induces EGFR and α5β1 integrin co-endocytosis in glioblastoma cells.

Blandin AF, Cruz Da Silva E, Mercier MC, Glushonkov O, Didier P, Dedieu S, Schneider C, Devy J, Etienne-Selloum N, Dontenwill M, Choulier L, Lehmann M

Cell Mol Life Sci. 2020 Nov 5;:

RNA Aptamers Targeting Integrin α5β1 as Probes for Cyto- and Histofluorescence in Glioblastoma.

Fechter P, Cruz Da Silva E, Mercier MC, Noulet F, Etienne-Seloum N, Guenot D, Lehmann M, Vauchelles R, Martin S, Lelong-Rebel I, Ray AM, Seguin C, Dontenwill M, Choulier L

Mol Ther Nucleic Acids. 2019 May 24;17:63-77

Role of Integrins in Resistance to Therapies Targeting Growth Factor Receptors in Cancer.

Cruz da Silva E, Dontenwill M, Choulier L, Lehmann M

Cancers (Basel). 2019 May 17;11(5):

BODIPY with Tuned Amphiphilicity as a Fluorogenic Plasma Membrane Probe.

Collot M, Boutant E, Lehmann M, Klymchenko AS

Bioconjug. Chem.. 2019 01 16;30(1):192-199

Synthesis and biological evaluation of 2.4 nm thiolate-protected gold nanoparticles conjugated to Cetuximab for targeting glioblastoma cancer cells via the EGFR.

Groysbeck N, Stoessel A, Donzeau M, Cruz da Silva E, Lehmann M, Strub JM, Cianferani S, Dembélé K, Zuber G

Nanotechnology. 2019 Jan 16;:

RND1 regulates migration of human glioblastoma stem-like cells according to their anatomical localization and defines a prognostic signature in glioblastoma.

Boyrie S, Delmas C, Lemarié A, Lubrano V, Dahan P, Malric L, Luis J, Gilhodes J, Tosolini M, Mouly L, Lehmann M, Toulas C, Cohen-Jonathan Moyal E, Monferran S

Oncotarget. 2018 Sep 18;9(73):33788-33803

Expression/activation of α5β1 integrin is linked to the β-catenin signaling pathway to drive migration in glioma cells.

Renner G, Noulet F, Mercier MC, Choulier L, Etienne-Selloum N, Gies JP, Lehmann M, Lelong-Rebel I, Martin S, Dontenwill M

Oncotarget. 2016 Sep;7(38):62194-62207

Glioma cell dispersion is driven by α5 integrin-mediated cell-matrix and cell-cell interactions.

Blandin AF, Noulet F, Renner G, Mercier MC, Choulier L, Vauchelles R, Ronde P, Carreiras F, Etienne-Selloum N, Vereb G, Lelong-Rebel I, Martin S, Dontenwill M, Lehmann M

Cancer Lett.. 2016 07;376(2):328-38

Caveolin-1-negative head and neck squamous cell carcinoma primary tumors display increased epithelial to mesenchymal transition and prometastatic properties.

Jung AC, Ray AM, Ramolu L, Macabre C, Simon F, Noulet F, Blandin AF, Renner G, Lehmann M, Choulier L, Kessler H, Abecassis J, Dontenwill M, Martin S

Oncotarget. 2015 Oct 12

Integrin alpha5beta1 and p53 convergent pathways in the control of anti-apoptotic proteins PEA-15 and survivin in high-grade glioma.

Renner G, Janouskova H, Noulet F, Koenig V, Guerin E, Bar S, Nuesch J, Rechenmacher F, Neubauer S, Kessler H, Blandin AF, Choulier L, Etienne-Selloum N, Lehmann M, Lelong-Rebel I, Martin S, Dontenwill M

Cell Death Differ. 2015 Oct 16

β1 Integrins as Therapeutic Targets to Disrupt Hallmarks of Cancer.

Blandin AF, Renner G, Lehmann M, Lelong-Rebel I, Martin S, Dontenwill M

Front Pharmacol. 2015 ;6:279

Single cell tracking assay reveals an opposite effect of selective small non-peptidic alpha5beta1 or alphavbeta3/beta5 integrin antagonists in U87MG glioma cells.

Ray AM, Schaffner F, Janouskova H, Noulet F, Rognan D, Lelong-Rebel I, Choulier L, Blandin AF, Lehmann M, Martin S, Kapp T, Neubauer S, Rechenmacher F, Kessler H, Dontenwill M

Biochim Biophys Acta. 2014 Sep;1840(9):2978-87